IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

• Main Authors: Agata Blasiak (Author), Jhin Jieh Lim (Author), Shirley Gek Kheng Seah (Author), Theodore Kee (Author), Alexandria Remus (Author), De Hoe Chye (Author), Pui San Wong (Author), Lissa Hooi (Author), Anh T. L. Truong (Author), Nguyen Le (Author), Conrad E. Z. Chan (Author), Rishi Desai (Author), Xianting Ding (Author), Brendon J. Hanson (Author), Edward Kai‐Hua Chow (Author), Dean Ho (Author)
• Format: Book
• Published: Wiley, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) led to multiple drug repurposing clinical trials that have yielded largely uncertain outcomes. To overcome this challenge, we used IDentif.AI, a platform that pairs experimental validation with artificial intellig...